Speakers’ corner proving big hit with attendees Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
RETINAWS: When the going gets tough, the tough get going Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
Free Paper Winner: PULSAR trial shows efficacy of aflibercept 8 mg in wet AMD Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
Specialists delve deep to unravel retinal mysteries Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
EVER Symposium: Defusing the ticking timebomb of high myopia Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
Charting EURETINA’s future: collaboration, standards, and cutting-edge research Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
AI, clinical trials & diabetic eye disease all on the menu at Imaging session Day 3 from Amsterdam 2023, Latest News / By Niall Slowey
Euretina reiterates support at Ukraine Symposium Day 3 from Amsterdam 2023, Latest News / By Niall Slowey
Opening Ceremony kicks off 23rd Euretina Congress Day 2 from Amsterdam 2023, Latest News / By Niall Slowey
